vs
NATURES SUNSHINE PRODUCTS INC（NATR）とRepay Holdings Corp（RPAY）の財務データ比較。上の社名をクリックして会社を切り替えられます
NATURES SUNSHINE PRODUCTS INCの直近四半期売上が大きい（$123.8M vs $78.6M、Repay Holdings Corpの約1.6倍）。NATURES SUNSHINE PRODUCTS INCの純利益率が高く（3.3% vs -178.3%、差は181.6%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs 0.4%）。Repay Holdings Corpの直近四半期フリーキャッシュフローが多い（$23.2M vs $7.6M）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs -1.3%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
Repay Holdings Corpは北米を主要市場とする決済テクノロジー企業で、小売、医療、自動車サービス、電子商取引などの業種の企業向けに、クレジット・デビットカード決済処理、ACH送金、POSシステム連携を含む統合決済ソリューションを提供し、顧客の業務効率化を支援しています。
NATR vs RPAY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $78.6M |
| 純利益 | $4.1M | $-140.1M |
| 粗利率 | 72.5% | 74.2% |
| 営業利益率 | 4.3% | -182.2% |
| 純利益率 | 3.3% | -178.3% |
| 売上前年比 | 4.7% | 0.4% |
| 純利益前年比 | 1379.4% | -3304.1% |
| EPS（希薄化後） | $0.23 | $-1.68 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $123.8M | $78.6M | ||
| Q3 25 | $128.3M | $77.7M | ||
| Q2 25 | $114.8M | $75.6M | ||
| Q1 25 | $113.2M | $77.3M | ||
| Q4 24 | $118.2M | $78.3M | ||
| Q3 24 | $114.6M | $79.1M | ||
| Q2 24 | $110.6M | $74.9M | ||
| Q1 24 | $111.0M | $80.7M |
| Q4 25 | $4.1M | $-140.1M | ||
| Q3 25 | $5.3M | $-6.4M | ||
| Q2 25 | $5.3M | $-102.3M | ||
| Q1 25 | $4.7M | $-7.9M | ||
| Q4 24 | $-321.0K | $-4.1M | ||
| Q3 24 | $4.3M | $3.2M | ||
| Q2 24 | $1.3M | $-4.1M | ||
| Q1 24 | $2.3M | $-5.2M |
| Q4 25 | 72.5% | 74.2% | ||
| Q3 25 | 73.3% | 74.4% | ||
| Q2 25 | 71.7% | 75.7% | ||
| Q1 25 | 72.1% | 75.9% | ||
| Q4 24 | 72.0% | 76.3% | ||
| Q3 24 | 71.3% | 77.8% | ||
| Q2 24 | 71.4% | 78.2% | ||
| Q1 24 | 71.2% | 76.2% |
| Q4 25 | 4.3% | -182.2% | ||
| Q3 25 | 7.0% | -3.9% | ||
| Q2 25 | 3.7% | -138.7% | ||
| Q1 25 | 5.4% | -4.7% | ||
| Q4 24 | 3.8% | -1.5% | ||
| Q3 24 | 4.6% | -0.9% | ||
| Q2 24 | 5.1% | -4.6% | ||
| Q1 24 | 4.2% | -3.1% |
| Q4 25 | 3.3% | -178.3% | ||
| Q3 25 | 4.2% | -8.3% | ||
| Q2 25 | 4.6% | -135.2% | ||
| Q1 25 | 4.2% | -10.3% | ||
| Q4 24 | -0.3% | -5.3% | ||
| Q3 24 | 3.8% | 4.1% | ||
| Q2 24 | 1.2% | -5.4% | ||
| Q1 24 | 2.1% | -6.5% |
| Q4 25 | $0.23 | $-1.68 | ||
| Q3 25 | $0.30 | $-0.08 | ||
| Q2 25 | $0.28 | $-1.15 | ||
| Q1 25 | $0.25 | $-0.09 | ||
| Q4 24 | $-0.02 | $-0.04 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $0.07 | $-0.04 | ||
| Q1 24 | $0.12 | $-0.06 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $115.7M |
| 総負債低いほど良い | — | $280.1M |
| 株主資本純資産 | $161.6M | $484.4M |
| 総資産 | $261.1M | $1.2B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.58× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.9M | $115.7M | ||
| Q3 25 | $95.6M | $95.7M | ||
| Q2 25 | $81.3M | $162.6M | ||
| Q1 25 | $86.5M | $165.5M | ||
| Q4 24 | $84.7M | $189.5M | ||
| Q3 24 | $78.7M | $168.7M | ||
| Q2 24 | $68.7M | $147.1M | ||
| Q1 24 | $77.8M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | $2.1M | $434.9M |
| Q4 25 | $161.6M | $484.4M | ||
| Q3 25 | $166.7M | $616.9M | ||
| Q2 25 | $163.7M | $633.7M | ||
| Q1 25 | $167.1M | $755.7M | ||
| Q4 24 | $161.0M | $761.3M | ||
| Q3 24 | $162.6M | $754.7M | ||
| Q2 24 | $156.4M | $815.4M | ||
| Q1 24 | $159.7M | $813.8M |
| Q4 25 | $261.1M | $1.2B | ||
| Q3 25 | $264.8M | $1.3B | ||
| Q2 25 | $254.9M | $1.4B | ||
| Q1 25 | $252.7M | $1.5B | ||
| Q4 24 | $240.9M | $1.6B | ||
| Q3 24 | $245.3M | $1.6B | ||
| Q2 24 | $235.8M | $1.5B | ||
| Q1 24 | $247.3M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | 0.01× | 0.53× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $23.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $23.2M |
| FCFマージンFCF / 売上 | 6.1% | 29.6% |
| 設備投資強度設備投資 / 売上 | 1.9% | 0.1% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | — |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $90.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $23.3M | ||
| Q3 25 | $18.5M | $32.2M | ||
| Q2 25 | $4.3M | $33.1M | ||
| Q1 25 | $2.6M | $2.5M | ||
| Q4 24 | $12.2M | $34.3M | ||
| Q3 24 | $9.6M | $60.1M | ||
| Q2 24 | $1.3M | $31.0M | ||
| Q1 24 | $2.2M | $24.8M |
| Q4 25 | $7.6M | $23.2M | ||
| Q3 25 | $16.8M | $32.1M | ||
| Q2 25 | $3.0M | $33.0M | ||
| Q1 25 | $1.5M | $2.4M | ||
| Q4 24 | $10.0M | $34.0M | ||
| Q3 24 | $7.9M | $59.8M | ||
| Q2 24 | $-2.0M | $30.5M | ||
| Q1 24 | $-1.5M | $24.7M |
| Q4 25 | 6.1% | 29.6% | ||
| Q3 25 | 13.1% | 41.3% | ||
| Q2 25 | 2.6% | 43.6% | ||
| Q1 25 | 1.3% | 3.0% | ||
| Q4 24 | 8.5% | 43.5% | ||
| Q3 24 | 6.9% | 75.6% | ||
| Q2 24 | -1.9% | 40.7% | ||
| Q1 24 | -1.4% | 30.6% |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 1.2% | 0.1% | ||
| Q1 25 | 1.0% | 0.2% | ||
| Q4 24 | 1.9% | 0.3% | ||
| Q3 24 | 1.5% | 0.3% | ||
| Q2 24 | 3.0% | 0.6% | ||
| Q1 24 | 3.3% | 0.1% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 18.52× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
